CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-23 | Schenkein David P Chief Executive Officer | Sale | −39,774 | $90.11 | $3.6M | 9,600 |
| 2018-05-23 | Schenkein David P Chief Executive Officer | Sale | −9,301 | $91.60 | $852K | 299 |
| 2018-05-23 | Schenkein David P Chief Executive Officer | Sale | −299 | $92.03 | $28K | 0 |
| 2018-05-23 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −49,374 | 16,193 | ||
| 2018-05-23 | Hoerter Steven L. Chief Commercial Officer | Option exercise | +2,050 | $39.76 | $82K | 2,050 |
| 2018-05-23 | Hoerter Steven L. Chief Commercial Officer | Sale | −2,050 | $85.76 | $176K | 0 |
| 2018-05-23 | Hoerter Steven L. Chief Commercial Officer | Option exercise · Stock option (right to buy) | −2,050 | 66,800 | ||
| 2018-05-23 | Biller Scott Chief Scientific Officer | Option exercise | +15,177 | $31.64 | $480K | 72,373 |
| 2018-05-23 | Biller Scott Chief Scientific Officer | Sale | −15,177 | $90.00 | $1.4M | 57,196 |
| 2018-05-23 | Biller Scott Chief Scientific Officer | Option exercise · Stock options (right to buy) | +15,177 | 14,862 | ||
| 2018-05-11 | Bowden Christopher Chief Medical Officer | Option exercise | +2,000 | $35.16 | $70K | 2,881 |
| 2018-05-11 | Bowden Christopher Chief Medical Officer | Sale | −840 | $84.81 | $71K | 2,041 |
| 2018-05-11 | Bowden Christopher Chief Medical Officer | Sale | −1,160 | $85.14 | $99K | 881 |
| 2018-05-11 | Bowden Christopher Chief Medical Officer | Option exercise · Stock option (right to buy) | −2,000 | 97,000 | ||
| 2018-05-08 | Bowden Christopher Chief Medical Officer | Option exercise | +2,000 | $35.16 | $70K | 2,881 |
| 2018-05-08 | Bowden Christopher Chief Medical Officer | Sale | −2,000 | $81.38 | $163K | 881 |
| 2018-05-08 | Bowden Christopher Chief Medical Officer | Option exercise · Stock option (right to buy) | −2,000 | 99,000 | ||
| 2018-05-07 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −3,000 | 22,154 | ||
| 2018-05-07 | Biller Scott Chief Scientific Officer | Option exercise | +3,000 | $9.05 | $27K | 60,196 |
| 2018-05-07 | Biller Scott Chief Scientific Officer | Sale | −3,000 | $81.81 | $245K | 57,196 |
Page 62 of 63 · 1,252 trades